Hannover House, Inc. - HHSE

HHSE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
HHSE	0	0.7	23.6	34.9	-4.2	51.1	-66	-56.7	-37.6	-100.0
S&P 500	-1.3	-1.8	1.0	5.9	10.6	30.4	25.4	88.1	187.6	33142.5

Compare HHSE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	HHSE
name	Hannover House, Inc.
price	0.01
changes percentage	0
change	0
day low	0.01
day high	0.01
year high	0.01
year low	0.00
market cap	6690228
price avg 50	0.01
price avg 200	0.01
exchange	PNK
volume	7500
avg volume	151846
open	0.01
previous close	0.01
eps	0
pe	None
earnings announcement	None
shares outstanding	983857000
timestamp	2024-11-14 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.0%

Overall Quarterly Financial Health: 45.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001069680
revenue	512742	203622	151.81
gross profit	284422	201122	41.42
gross profit ratio	0.55	0.99	-43.84
research and development expenses	0	0	NaN
operating expenses	178409	106066	68.21
interest income	0	0	NaN
interest expense	59036	58413	1.07
ebitda	106010	95060	11.52
ebitdaratio	0.21	0.47	-55.71
operating income	106010	95060	11.52
operating income ratio	0.21	0.47	-55.71
net income	46977	36643	28.20
net income ratio	0.09	0.18	-49.09
eps	0	0	NaN

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1 million in 2023 from 0 million in 2022 representing a change of 151.81%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 0 million in 2023 from 0 million in 2022 representing a change of 41.42%. This indicates a sales profitability growth, which is a positive sign for the company.

  Net Income: Net income increased to 0 million in 2023 from 0 million in 2022 representing a change of 28.2%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 0 million in 2023 from 0 million in 2022 representing a change of 68.21%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 0 million in 2023 from 0 million in 2022 representing a change of 11.52%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 0 million in 2023 from 0 million in 2022 representing a change of 11.52%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001069680
revenue	371599	64977	471.89
gross profit	371599	64977	471.89
gross profit ratio	1	1	0.00
research and development expenses	0	0	NaN
operating expenses	40560	26886	50.86
interest income	0	0	NaN
interest expense	22759	21789	4.45
ebitda	331039	38090	769.10
ebitdaratio	0.89	0.59	51.97
operating income	331040	38090	769.10
operating income ratio	0.89	0.59	51.97
net income	308280	16303	1,790.94
net income ratio	0.83	0.25	230.65
eps	0.0	0	NaN

Overall Score of Quarterly Income Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 471.89%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 50.86%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 769.1%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 769.1%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 471.89%. This indicates a sales profitability growth, which is a positive sign for the company.

  Net Income: Net income increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 1790.94%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001069680
total assets	36831223	38349848	-3.96
total liabilities	3048370	3977752	-23.36
total equity	33782853	34372096	-1.71
cash and cash equivalents	21676	3473	524.13
short term investments	0	688386	-100.00
long term investments	0	0	NaN
total current assets	6360586	7890096	-19.39
total non current assets	30470637	30459752	0.04
total current liabilities	1615307	1967178	-17.89
total non current liabilities	1433062	2010574	-28.72
common stock	31704503	31039404	2.14
retained earnings	2078350	3332692	-37.64
total debt	1411376	1519642	-7.12

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 37 million in 2023 from 38 million in 2022 representing a change of -3.96%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 34 million in 2023 from 34 million in 2022 representing a change of -1.71%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 1 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 6 million in 2023 from 8 million in 2022 representing a change of -19.39%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 2 million in 2023 from 3 million in 2022 representing a change of -37.64%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 3 million in 2023 from 4 million in 2022 representing a change of -23.36%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2023 from 0 million in 2022 representing a change of 524.13%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 2 million in 2023 from 2 million in 2022 representing a change of -17.89%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 32 in 2023 from 31 in 2022 representing a change of 2.14%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 1 million in 2023 from 2 million in 2022 representing a change of -7.12%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001069680
total assets	37175206	36812941	0.98
total liabilities	3116973	3081879	1.14
total equity	34058233	33731062	0.97
cash and cash equivalents	7222	3394	112.79
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	6704569	6342304	5.71
total non current assets	30470637	30470637	0.00
total current liabilities	1625708	1625708	0.00
total non current liabilities	1491265	1456170	2.41
common stock	31636409	31636409	0.00
retained earnings	2421824	2094653	15.62
total debt	1467078	1423484	3.06

Overall Score of Quarterly Balance Sheet

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 37 million in 2024Q2 from 37 million in 2024Q1 representing a change of 0.98%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 34 million in 2024Q2 from 34 million in 2024Q1 representing a change of 0.97%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 112.79%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 7 million in 2024Q2 from 6 million in 2024Q1 representing a change of 5.71%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 2 million in 2024Q2 from 2 million in 2024Q1 representing a change of 15.62%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 3 million in 2024Q2 from 3 million in 2024Q1 representing a change of 1.14%. This indicates an increase in overall liabilities.

  Total Debt: Total Debt increased to 1 million in 2024Q2 from 1 million in 2024Q1 representing a change of 3.06%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001069680
net change in cash	18203	-3571	609.75
operating cash flow	383839	41566	823.44
free cash flow	383840	41566	823.45
capital expenditure	1	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-21348	-4000	-433.70
inventory	0	4000	-100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	1	0	NaN
net cash used for investing activites	724038	-115702	725.78
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	186660	67121	178.09
cash at end of period	21676	3473	524.13
accounts receivables	358190	28500	1,156.81
cash at beginning of period	3473	7044	-50.70

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2023 from 0 million in 2022 representing a change of 609.75%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 0 million in 2023 from 0 million in 2022 representing a change of 823.44%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 0 million in 2023 from 0 million in 2022 representing a change of 823.45%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2023 from 0 million in 2022 representing a change of -433.7%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 0 in 2023 from 0 million in 2022 representing a change of 1156.81%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001069680
operating cash flow	-14031	195049	-107.19
free cash flow	0	195049	-100.00
capital expenditure	14031	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	75000	-100.00
accounts payables	-113997	98275	-216.00
inventory	0	-98275	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	14031	0	NaN
net cash used for investing activites	71102	214383	-66.83
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	202775	0	NaN
net change in cash	19334	-19334	200.00
cash at end of period	21676	2342	825.53
cash at beginning of period	2342	21676	-89.20

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 200.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -107.19%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -100.0%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of nan%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -216.0%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.0	0.0	144.62
net income per share	0.0	0.0	24.54
operating cash flow per share	0.0	0.0	797.09
free cash flow per share	0.0	0.0	797.09
cash per share	0.0	0.0	-96.96
book value per share	0.03	0.03	-4.52
tangible book value per share	0.03	0.03	-4.52
shareholders equity per share	0.03	0.03	-4.52
interest debt per share	0.0	0.0	-9.48
market cap	5772762.46	6099912.45	-5.36
enterprise value	7162462.46	7616081.45	-5.96
pe ratio	122.88	166.47	-26.18
price to sales ratio	11.26	29.96	-62.42
pocfratio	15.04	146.75	-89.75
pfcf ratio	15.04	146.75	-89.75
pb ratio	0.17	0.18	-3.71
ptb ratio	0.17	0.18	-3.71
ev to sales	13.97	37.4	-62.65
enterprise value over ebitda	67.56	80.12	-15.67
ev to operating cash flow	18.66	183.23	-89.82
ev to free cash flow	18.66	183.23	-89.82
earnings yield	0.01	0.01	35.47
free cash flow yield	0.07	0.01	875.78
debt to equity	0.04	0.04	-5.50
debt to assets	0.04	0.04	-3.29
net debt to ebitda	13.11	15.95	-17.81
current ratio	3.94	4.01	-1.82
interest coverage	1.8	1.63	10.34
income quality	8.17	1.13	620.31
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.0	0	NaN
capex to revenue	0.0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.01	0.01	9.05
roic	0.01	0.02	-28.10
return on tangible assets	0.0	0.0	33.49
graham net net	-0.0	-0.0	-489.45
working capital	4745279	5922918	-19.88
tangible asset value	33782853	34372096	-1.71
net current asset value	3312216	3912344	-15.34
invested capital	4776615	5943369	-19.63
average receivables	2771588.5	3913002.5	-29.17
average payables	40354.5	48635.5	-17.03
average inventory	100704	100704	0.00
days sales outstanding	1150.87	7038.34	-83.65
days payables outstanding	51.95	7038.66	-99.26
days of inventory on hand	160.99	14702.78	-98.91
receivables turnover	0.32	0.05	511.57
payables turnover	7.03	0.05	13,447.87
inventory turnover	2.27	0.02	9,032.80
roe	0.0	0.0	30.44
capex per share	0.0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.00 on 2023-12-31 from 0.00 on 2022-12-31, representing a change of 30.44%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 122.88 on 2023-12-31 from 166.47 on 2022-12-31, representing a change of -26.18%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 3.94 on 2023-12-31 from 4.01 on 2022-12-31, representing a change of -1.82%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2023-12-31 from 0.04 on 2022-12-31, representing a change of -5.50%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
HHSE
calendar year	2024	2024	NaN
revenue per share	0.0	0.0	471.89
net income per share	0.0	0.0	1,790.94
operating cash flow per share	None	None	NaN
free cash flow per share	None	None	NaN
cash per share	0.0	0.0	112.79
book value per share	0.03	0.03	0.97
tangible book value per share	0.03	0.03	0.97
shareholders equity per share	0.03	0.03	0.97
interest debt per share	0.0	0.0	3.08
market cap	5893895.15	6735880.17	-12.50
enterprise value	7353751.15	8155970.17	-9.84
pe ratio	4.78	103.29	-95.37
price to sales ratio	15.86	103.67	-84.70
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	0.17	0.2	-13.34
ptb ratio	0.17	0.2	-13.34
ev to sales	19.79	125.52	-84.23
enterprise value over ebitda	22.21	214.12	-89.63
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	0.05	0.0	2,061.07
free cash flow yield	None	None	NaN
debt to equity	0.04	0.04	2.07
debt to assets	0.04	0.04	2.06
net debt to ebitda	4.41	37.28	-88.17
current ratio	4.12	3.9	5.71
interest coverage	14.55	1.75	732.06
income quality	0	0	NaN
dividend yield	None	None	NaN
payout ratio	None	None	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	None	None	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	None	None	NaN
graham number	0.01	0.0	336.95
roic	0.01	0.0	135.34
return on tangible assets	0.01	0.0	1,772.51
graham net net	-0.0	-0.0	13.11
working capital	5078861	4716596	7.68
tangible asset value	34058233	33731062	0.97
net current asset value	3587596	3260425	10.03
invested capital	5110197	4747932	7.63
average receivables	1796709	1616709	11.13
average payables	32499	32499	0.00
average inventory	99922.5	100704	-0.78
days sales outstanding	478.75	2239.31	-78.62
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0.19	0.04	367.74
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.01	0.0	1,772.78
capex per share	None	None	NaN

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-06-30 Q2 from 0.00 on 2024-03-31 Q1, representing a change of 1772.78%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.78 on 2024-06-30 Q2 from 103.29 on 2024-03-31 Q1, representing a change of -95.37%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 4.12 on 2024-06-30 Q2 from 3.90 on 2024-03-31 Q1, representing a change of 5.71%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of 2.07%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None